Cite
HARVARD Citation
Pinjusic, K. et al. (2022). Activin-A impairs CD8 T cell-mediated immunity and immune checkpoint therapy response in melanoma. Journal for immunotherapy of cancer. 10 (5), p. . [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Pinjusic, K. et al. (2022). Activin-A impairs CD8 T cell-mediated immunity and immune checkpoint therapy response in melanoma. Journal for immunotherapy of cancer. 10 (5), p. . [Online].